Pamela Jo Harris

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Mitesh J. Borad, Mia D. Champion, Jan B. Egan et al. · PLoS Genetics · 2014 · 334 citations · Full text

Fgfr Inhibitors, Pathology, Sporadic Intrahepatic Cholangiocarcinoma +19

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

Keith C. Bible, Vera J. Suman, Michael E. Menefee et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 170 citations · Full text

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

Julia Glade Bender, Alice Lee, Joel M. Reid et al. · Journal of Clinical Oncology · 2013 · 159 citations · Full text

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H

Keith C. Bible, Vera J. Suman, Julian R. Molina et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 117 citations · Full text

Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer.

Michael Boyer, Derek Raghavan, Pamela Jo Harris et al. · Journal of Clinical Oncology · 1990 · 92 citations

Cisplatin-based Combination Chemotherapy, Urology, Chemoprevention Strategy +15